Global Pain Management Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

SKU ID : GIR-13860740 | Publishing Date : 18-Feb-2019 | No. of pages : 136

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

Scope of the Report:
The classification of pain management drugs includes opioids, NSAIDs and other types, and the proportion of opioids is about 47% in 2016, and the proportion is in decreasing trend from 2012 to 2017.
North America is the largest consumption place, with a consumption market share nearly 37% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
Market competition is intense. Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Pain Management Drugs is expected to grow at a CAGR of roughly 2.8% over the next five years, will reach 41900 million US$ in 2024, from 35600 million US$ in 2019, according to a new study.
This report focuses on the Pain Management Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Generic Opioids
Branded Opioids
NSAIDs
Others

Market Segment by Applications, can be divided into
Hospitals
Clinics
Drugstores

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pain Management Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pain Management Drugs, with price, sales, revenue and global market share of Pain Management Drugs in 2017 and 2018.
Chapter 3, the Pain Management Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pain Management Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Pain Management Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Pain Management Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
PRICE
3480
6960


  • market Reports market Reports